RDNT
RadNet, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$69.27
+0.68%Forward multiples
Based on analyst estimates
- P/E forward
- 104.73x
- P/E 2026E
- 134.59x
- P/E 2027E
- 78.07x
- P/E 2028E
- 62.36x
- P/S forward
- 2.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.97x
- Price / sales
- 2.40x
- Price / cash flow
- 17.20x
Enterprise value
- Enterprise value
- $7.2B
- EV / sales
- 3.18x
- EV / EBITDA
- 25.97x
- EV / EBIT
- 79.32x
- Market cap
- $5.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026